The risk-benefit assessment of liver biopsy in times of non-invasive screening for liver fibrosis. Ilic I, Milovanovic T. J Hepatol 2020;73:701-702.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ilic I, Milovanovic T. The risk-benefit assessment of liver biopsy in times of non-invasive screening for liver fibrosis. J Hepatol 2020;73:701-702.
PMID: 32546400